2021 Global AI Medical Device Industry Market Size and Segmentation Forecast Analysis (Chart)

Artificial intelligence (AI) medical devices refer to medical devices that use artificial intelligence technology, including independent AI software and AI software components. Their applications in assisting treatment and medical image processing are increasingly widespread, making them a hot topic in the medical device industry.

　　The global market size of AI medical devices increased from \$0.9 billion in 2016 to \$3.6 billion in 2020, with a compound annual growth rate (CAGR) of 42.4% from 2016 to 2020. It is expected to further increase to \$6.7 billion in 2021.

　　Data source: Frost & Sullivan, Zheshang Industry Research Institute

　　AI medical devices are used in the diagnosis and treatment of various diseases. Among them, the largest market segment for AI medical devices is in the cancer field (31%), followed by infectious diseases (20%) and pneumonia diagnosis (13%), with the remaining segments holding smaller shares.

　　Data source: Frost & Sullivan, Zheshang Industry Research Institute

　　The global market size of AI medical devices in the cancer field increased from \$31.4 million in 2016 to \$106.4 million in 2020, representing a CAGR of 35.7% from 2016 to 2020. It is expected to reach \$5,912.9 million in 2025, with a CAGR of 123.4% from 2020 to 2025.

　　Data source: Frost & Sullivan, Zheshang Industry Research Institute

　　Due to their ability to identify characteristic patterns from complex data, AI tools have helped address the challenges during the COVID-19 pandemic. The global market size of AI infectious disease medical devices increased from \$0.9 million in 2016 to \$71.1 million in 2020, with a CAGR of 198.13%. The growth rate significantly increased between 2019 and 2020, and it is expected to reach \$187.4 million in 2021.

　　Data source: Frost & Sullivan, Zheshang Industry Research Institute

　　Due to the pandemic, pneumonia diagnostic devices began to be used from 2020 onwards. AI pneumonia screening and diagnostic devices aim to assist in the triage and assessment of pneumonia. The global market size of AI pneumonia diagnostic medical devices increased from \$46.2 million in 2020 to \$182 million in 2022, with a CAGR of 98.48% from 2020 to 2022. The market is expected to reach \$112.4 million in 2021.

　　Data source: Frost & Sullivan, Zheshang Industry Research Institute

　　Bodily trauma is a serious injury to the body. Bodily trauma is mainly divided into blunt trauma and penetrating trauma. Rib fractures are usually caused by blunt trauma. The global market size of AI fracture diagnostic medical devices increased from \$7.1 million in 2016 to \$27.6 million in 2020, representing a CAGR of 40.4% from 2016 to 2020, and it is expected to further increase to \$47.8 million in 2021.

　　Data source: Frost & Sullivan, Zheshang Industry Research Institute

　　Pulmonary nodules are abnormal growths that form in the lungs; they can be benign or malignant. If the growth is larger than 3 centimeters (or called a lung mass), it may indicate a higher probability of malignancy. The global market size of AI pulmonary nodule detection medical devices increased from \$6.0 million in 2016 to \$26.7 million in 2020, with a CAGR of 45.5% from 2016 to 2020. It is expected to further increase to \$50.2 million in 2021.

　　Data source: Frost & Sullivan, Zheshang Industry Research Institute

　　Tuberculosis is one of the top ten causes of death worldwide. Tuberculosis is caused by a bacterium called Mycobacterium tuberculosis, which can attack any part of the body, such as the kidneys, spine, and brain. The global market size of AI tuberculosis diagnostic medical devices increased from \$0.9 million in 2016 to \$24.9 million in 2020, with a CAGR of 131.6% from 2016 to 2020. It is expected to further increase to \$62.3 million in 2021.

　　Data source: Frost & Sullivan, Zheshang Industry Research Institute

　　Stroke is the interruption of blood flow to the brain due to a blockage or rupture of a brain artery, resulting in acute damage to brain cells due to lack of oxygen. The global market size increased from \$2.8 million in 2016 to \$17.5 million in 2020, with a CAGR of 58.0% from 2016 to 2020. It is expected to further increase to \$29.1 million in 2021.

　　Data source: Frost & Sullivan, Zheshang Industry Research Institute

　　The lung has a complex anatomical structure, such as bronchi, vascular branches, and alveoli. Preoperative planning plays an important role in reducing intraoperative complications. The global market size of AI medical devices used for lung preoperative planning increased from \$3.8 million in 2016 to \$13.8 million in 2020, with a CAGR of 38.4% from 2016 to 2020. It is expected to reach \$25.2 million in 2021.

　　Data source: Frost & Sullivan, Zheshang Industry Research Institute

　　Coronary heart disease is caused by narrowing or blockage of the coronary arteries. Coronary heart disease is the most common organ disease caused by atherosclerosis, with high morbidity and mortality rates. The global market size of AI coronary heart disease diagnostic medical devices increased from \$8.0 million in 2018 to \$12.7 million in 2020, with a CAGR of 25.8%, and will further increase to \$34.9 million in 2021.

　　Data source: Frost & Sullivan, Zheshang Industry Research Institute

　　Currently, the vast majority of the global AI medical device market is experiencing growth, with a small portion experiencing a significant increase due to the impact of the recent novel tubular virus outbreak. In the future, the AI medical device market will continue to develop.

This data is sourced from the internet. Please contact us for removal if there is any infringement.